All the news Showing 10 of 78 articles from: Triple therapyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Simeprevir cures almost 80% of first-time co-infected hepatitis C patients Keith Alcorn / 14 March 2014 The next-generation hepatitis C protease inhibitor simeprevir cured almost 80% of previously untreated people with hepatitis C and HIV co-infection when used in combination with pegylated interferon and ribavirin, Prof. Doug Dieterich of ... Treating HCV -- Is the Price Right? Med Page Today / 19 February 2014 Deferral of treatment in HCV patients: Risks and benefits Hepatitis B & C Public Policy Association / 17 February 2014 US medical societies launch new hepatitis C treatment guidelines Liz Highleyman / 30 January 2014 The American Association for the Study of Liver Diseases (AASLD), Infectious Diseases Society of America (IDSA) and International Antiviral Society-USA (IAS-USA) yesterday announced the first new hepatitis C treatment guidelines ... Experimental treatment cures Ottawa wrestler of hepatitis C CBC / 14 January 2014 Phase III data show Boehringer Ingelheim’s faldaprevir is effective even in patients with common drug-resistant viral variant Boehringer-Ingelheim press release / 16 December 2013 Faldaprevir safe and effective in HCV treatment-experienced patients Michael Carter / 13 December 2013 Triple therapy including the investigational hepatitis C virus (HCV) protease inhibitor faldaprevir is a safe and effective treatment for people who did not respond to a previous course of HCV treatment, results of ... US FDA approves Gilead's $1000-a-day hepatitis C pill Reuters / 08 December 2013 FDA approves Sovaldi for chronic hepatitis C US FDA / 08 December 2013 FDA approves new treatment for hepatitis C virus FDA / 26 November 2013 ← Prev12345...8Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive